Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
Study on the Safety and Effectiveness of ESK-001 for Adults with Systemic Lupus Erythematosus
BulgariaStudy on the Effects of HZN-1116 for Patients with Sjögren’s Syndrome
AustriaStudy on the Effects of Vibozilimod for Adults with Moderate to Severe Atopic Dermatitis
EstoniaStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
AustriaStudy on the Effectiveness and Safety of Bimekizumab and Risankizumab in Adults with Active Psoriatic Arthritis
BulgariaEfficacy and Safety of Tirzepatide Versus Placebo in Adults with Type 1 Diabetes and Obesity or Overweight: A Phase 3 Randomized Controlled Trial
DenmarkDrug interaction study of leniolisib with a drug combination in healthy volunteers for Activated PI3K Delta Syndrome
GermanyStudy on Ritlecitinib for Adults and Adolescents with Nonsegmental Vitiligo
BulgariaPharmacokinetic Study of Ritlecitinib Tosilate in Healthy Adults: Oral Solution, Short‑and Long‑Duration Capsules Fed vs Fasted – for ulcerative colitis
BelgiumEfficacy and safety of eplontersen sodium plus ALXN2220 in adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM)
FrancePhase 2 Study of Daxdilimab with Prednisone in Adults with Inadequately Controlled Dermatomyositis or Anti‑Synthetase Inflammatory Myositis
CzechiaDose‑finding trial of a mannan‑conjugated Phleum pratense/Dactylis glomerata allergoid vaccine in patients with grass‑pollen allergic rhinitis or rhinoconjunctivitis
GermanyThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
